Skip to content

Released Nov 12, 2024, before the open

10-Q filed Nov 12, 2024, 43 days after period end · 0001628280-24-046824

Q3 2024 · 10-Q
Revenue$101.85M+47.1% vs Q3 2023+1.7% vs Q2 2024
Net Income-$41.67MN/M vs Q3 2023N/M vs Q2 2024
EPS Diluted-$0.04N/M vs Q3 2023N/M vs Q2 2024
Operating Income-$67,853,000N/M
Operating Cash Flowderived-$26,821,000N/M
Free Cash Flowderived-$28,163,000N/M
Margins · derived
Operating margin-66.6%+54.1 pt vs Q3 2023
Net margin-40.9%+59.0 pt vs Q3 2023

What the release said

The release

Same quarter

MetricQ3 2024Q3 2023Q3 2022Q3 2021
Revenue$101.85M$69.23M$56.96M$43.10M
Net Income-$41.67M-$69.15M-$161.19M-$96.41M
EPS Diluted-$0.04-$0.07-$0.17-$0.10

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Zai Lab Ltd · CIK 1704292 · Engraved from SEC EDGAR